OBJECTIVE: To determine the prevalence and causation of late onset cerebellar ataxia (LOCA) in south east Wales, United Kingdom. METHODS: A population based study of LOCA was conducted in a defined geographical region with a total population of 742,400. Multiple sources of ascertainment were used to identify all cases prevalent on 1 January 2001. The inclusion criteria were: a predominantly progressive cerebellar ataxia with onset of symptoms at age > or = 18 years; and disease duration of > or = 1 year. Cases with known acquired ataxias, ataxic syndromes with associated prominent autonomic dysfunction and/or atypical parkinsonism suggestive of multiple system atrophy and disorders with ataxia as a minor feature were excluded. RESULTS: We identified 76 index cases of LOCA, of whom 63 were sporadic, idiopathic LOCA (ILOCA) and 13 were familial LOCA, of whom six had either spinocerebellar ataxia type 6, Friedreich's ataxia or dominant episodic ataxia. The mean annual incidence rate for the period 1999-2001 was 0.3/100,000 population/year. The crude prevalence rates were 8.4 per 100,000 (95% CI 7.2 to 11.6) for ILOCA and 1.8 per 100,000 (95% CI 0.8 to 2.7) for inherited LOCA. Of the 54/63 (85.7%) patients with ILOCA who were assessed, mean (SD) age at onset of symptoms was 53.8 (14.1) years (range 19 to 78) with a male:female ratio of 2.1:1. The mean disease duration was 8.7 (6.3) years (range 1 to 31). The most frequent presenting complaint was disturbance in gait (90.7%). One-third had a relatively pure cerebellar syndrome (33.3%) and two-thirds (66.7%) had additional extracerebellar neurological features. The majority (92%) were ambulant but only 9.3% were independently self-caring. CONCLUSION: This population based study provides insight into LOCA within a defined region and will inform decisions about the rational use of healthcare resources for patients with LOCA.
OBJECTIVE: To determine the prevalence and causation of late onset cerebellar ataxia (LOCA) in south east Wales, United Kingdom. METHODS: A population based study of LOCA was conducted in a defined geographical region with a total population of 742,400. Multiple sources of ascertainment were used to identify all cases prevalent on 1 January 2001. The inclusion criteria were: a predominantly progressive cerebellar ataxia with onset of symptoms at age > or = 18 years; and disease duration of > or = 1 year. Cases with known acquired ataxias, ataxic syndromes with associated prominent autonomic dysfunction and/or atypical parkinsonism suggestive of multiple system atrophy and disorders with ataxia as a minor feature were excluded. RESULTS: We identified 76 index cases of LOCA, of whom 63 were sporadic, idiopathic LOCA (ILOCA) and 13 were familial LOCA, of whom six had either spinocerebellar ataxia type 6, Friedreich's ataxia or dominant episodic ataxia. The mean annual incidence rate for the period 1999-2001 was 0.3/100,000 population/year. The crude prevalence rates were 8.4 per 100,000 (95% CI 7.2 to 11.6) for ILOCA and 1.8 per 100,000 (95% CI 0.8 to 2.7) for inherited LOCA. Of the 54/63 (85.7%) patients with ILOCA who were assessed, mean (SD) age at onset of symptoms was 53.8 (14.1) years (range 19 to 78) with a male:female ratio of 2.1:1. The mean disease duration was 8.7 (6.3) years (range 1 to 31). The most frequent presenting complaint was disturbance in gait (90.7%). One-third had a relatively pure cerebellar syndrome (33.3%) and two-thirds (66.7%) had additional extracerebellar neurological features. The majority (92%) were ambulant but only 9.3% were independently self-caring. CONCLUSION: This population based study provides insight into LOCA within a defined region and will inform decisions about the rational use of healthcare resources for patients with LOCA.
Authors: A Filla; G De Michele; L Santoro; O Calabrese; I Castaldo; S Giuffrida; D Restivo; L Serlenga; D F Condorelli; U Bonuccelli; R Scala; G Coppola; G Caruso; S Cocozza Journal: J Neurol Date: 1999-06 Impact factor: 4.849
Authors: E Storey; D du Sart; J H Shaw; P Lorentzos; L Kelly; R J McKinley Gardner; S M Forrest; I Biros; G A Nicholson Journal: Am J Med Genet Date: 2000-12-11
Authors: P Basu; B Chattopadhyay; P K Gangopadhaya; S C Mukherjee; K K Sinha; S K Das; S Roychoudhury; P P Majumder; N P Bhattacharyya Journal: Hum Genet Date: 2000-06 Impact factor: 4.132
Authors: O Gebus; S Montaut; B Monga; T Wirth; C Cheraud; C Alves Do Rego; I Zinchenko; G Carré; M Hamdaoui; G Hautecloque; L Nguyen-Them; B Lannes; J B Chanson; O Lagha-Boukbiza; M C Fleury; D Devys; G Nicolas; G Rudolf; M Bereau; M Mallaret; M Renaud; C Acquaviva; M Koenig; M Koob; S Kremer; I J Namer; C Cazeneuve; A Echaniz-Laguna; C Tranchant; Mathieu Anheim Journal: J Neurol Date: 2017-05-06 Impact factor: 4.849
Authors: T Bogdan; T Wirth; A Iosif; A Schalk; S Montaut; C Bonnard; G Carre; O Lagha-Boukbiza; C Reschwein; E Albugues; S Demuth; H Landsberger; M Einsiedler; T Parratte; A Nguyen; F Lamy; H Durand; P Fahrer; P Voulleminot; K Bigaut; J B Chanson; G Nicolas; J Chelly; C Cazeneuve; M Koenig; C Bund; I J Namer; S Kremer; N Calmels; C Tranchant; M Anheim Journal: J Neurol Date: 2022-07-23 Impact factor: 6.682
Authors: Wafaa Ma Farghaly; Hamdy N El-Tallawy; Ghaydaa A Shehata; Tarek A Rageh; Nabil Abdel Hakeem; Noha M Abo-Elfetoh Journal: Neuropsychiatr Dis Treat Date: 2011-04-05 Impact factor: 2.570